
US Practice Patterns and Impact of Monitoring for Mucosal Inflammation After Biologic Initiation in Inflammatory Bowel Disease
Author(s) -
Berkeley N. Limketkai,
Siddharth Singh,
Vipul Jairath,
William J. Sandborn,
Parambir S. Dulai
Publication year - 2019
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izz081
Subject(s) - medicine , ulcerative colitis , calprotectin , inflammatory bowel disease , hazard ratio , faecal calprotectin , gastroenterology , disease , crohn's disease , biomarker , confidence interval , biochemistry , chemistry
We assessed practice patterns for monitoring mucosal inflammation after biologic initiation and the association between monitoring approaches and development of disease-related complications for Crohn's disease (CD) and ulcerative colitis (UC).